source Post navigation Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes – Yahoo Finance Young age at first menstrual cycle linked to heightened diabetes risk in mid-life – Medical Xpress